GMA with MOVIVA®: setting new standards in endoscopic bariatric treatment

Contributed by: Business Wire

Logo

Business Wire logo

Images

GMA with MOVIVA®
GMA with MOVIVA®
MOVIVA®: Hybrid technology for Endoscopic Gastric Mucosal Ablation
MOVIVA®: Hybrid technology for Endoscopic Gastric Mucosal Ablation
Business Wire embedded0

Tags

Technology
Medical Devices
Other Technology
Health Technology
Biotechnology
Other Health
Hardware
Health
General Health
GMA with MOVIVA

More Like This

How GMA with MOVIVA® works

MOVIVA® launch spotlight at ESGE Days 2026

BariaTek Medical Announces the First-in-Human Implantation of Its BariTon™ Device, a Non-Surgical Gastro-Intestinal Medical Device Aiming to Replicate the Efficacy of Obesity Surgery Without the Invasiveness

ESGE Days 2026: Endoscopic procedure associated with greater short-term weight loss than oral semaglutide, study finds

PR Newswire associated0

Nitinotes Announces First EASE™ Clinical Trial Procedures at Fondazione Policlinico Universitario Agostino Gemelli IRCCS in Italy

Endo Tools Therapeutics Secures $23 million in Series C Financing to Advance The endomina® technology and Commercialization of New endomina EZFuse System

VIO 3n Fire

Erbe introduces VIO® 3n & VIO® seal: Tailored electrosurgical generators for high-performance workflows

Business Wire logo

BeiGene Receives Positive CHMP Opinions for TEVIMBRA® as a First-Line Treatment for Advanced/Metastatic Gastric or Gastroesophageal Junction Cancer and Esophageal Squamous Cell Carcinoma

Implantica's RefluxStop™ now available in Munich